AI to help more patients get prostate cancer drug that cuts risk of death

Researchers found abiraterone reduced the risk of death among biomarker-positive patients from 17 per cent to 9 per cent -

AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers have said.

A recent study found that AI can identify patients who will benefit most from Abiraterone, a "game changer" drug.